Pulmonary Hypertension

Patient Age Linked With Specific PAH Clinical Profile and Prognosis    Pulmonology Advisor Patients with pulmonary hypertension age ≥65 years have worse long-term survival compared with younger patients.

A Decidedly Darker Prognosis for Takotsubo Syndrome    Medscape Takotsubo syndrome (TS) has been considered a transient benign disorder, but mounting evidence of a darker long-term prognosis is reshaping that belief.

Prognostic Relevance of Cardiopulmonary Exercise Testing in Low-Risk Pulmonary Arterial Hypertension    The Cardiology Advisor Combinations of VO2 and change in CI during follow-up visits are valuable prognosis markers in low-risk patients with PAH.

PAH: An Under-Recognized Complication of Adult-Onset Still's Disease    The Cardiology Advisor PAH hypertension is an under-diagnosed complication of adult-onset Still disease.

Repeated Measurements of Biomarkers May Improve Prognostic Accuracy in PAH-CHD Patients, Study Finds    Pulmonary Hypertension News Repeated measurements of different biomarkers over time offers better risk prediction than single measurements for PAH-CHD, a study says.

Patient Age Linked With Specific PAH Clinical Profile and Prognosis    Pulmonology Advisor Patients with pulmonary hypertension age ≥65 years have worse long-term survival compared with younger patients.

Prognostic Relevance of Cardiopulmonary Exercise Testing in Low-Risk Pulmonary Arterial Hypertension    The Cardiology Advisor Combinations of VO2 and change in CI during follow-up visits are valuable prognosis markers in low-risk patients with PAH.

PAH: An Under-Recognized Complication of Adult-Onset Still's Disease    The Cardiology Advisor PAH hypertension is an under-diagnosed complication of adult-onset Still disease.

A Decidedly Darker Prognosis for Takotsubo Syndrome    Medscape Takotsubo syndrome (TS) has been considered a transient benign disorder, but mounting evidence of a darker long-term prognosis is reshaping that belief.

Repeated Measurements of Biomarkers May Improve Prognostic Accuracy in PAH-CHD Patients, Study Finds    Pulmonary Hypertension News Repeated measurements of different biomarkers over time offers better risk prediction than single measurements for PAH-CHD, a study says.

NICE 2018 Guideline on diagnosis of COPD    Specialty Medical Dialogues NICE has released its updated 2018 guidelines on diagnosis of Chronic obstructive pulmonary disease in over 16s.COPD is a common, preventable and ...

NICE 2018 Guideline on diagnosis of COPD    Specialty Medical Dialogues NICE has released its updated 2018 guidelines on diagnosis of Chronic obstructive pulmonary disease in over 16s.COPD is a common, preventable and ...

NICE 2018 Guideline on diagnosis of COPD    Specialty Medical Dialogues NICE has released its updated 2018 guidelines on diagnosis of Chronic obstructive pulmonary disease in over 16s.COPD is a common, preventable and ...

NICE 2018 Guideline on diagnosis of COPD    Specialty Medical Dialogues NICE has released its updated 2018 guidelines on diagnosis of Chronic obstructive pulmonary disease in over 16s.COPD is a common, preventable and ...

NICE 2018 Guideline on diagnosis of COPD    Specialty Medical Dialogues NICE has released its updated 2018 guidelines on diagnosis of Chronic obstructive pulmonary disease in over 16s.COPD is a common, preventable and ...

NICE 2018 Guideline on diagnosis of COPD    Specialty Medical Dialogues NICE has released its updated 2018 guidelines on diagnosis of Chronic obstructive pulmonary disease in over 16s.COPD is a common, preventable and ...

FDA Approves Sprycel for Pediatric ALL    Curetoday.com The Food and Drug Administration (FDA) approved Sprycel (dasatinib) plus chemotherapy for the treatment of pediatric patients with newly diagnosed ...

FDA Approves Sprycel for Pediatric ALL    Curetoday.com The Food and Drug Administration (FDA) approved Sprycel (dasatinib) plus chemotherapy for the treatment of pediatric patients with newly diagnosed ...

Top 10 Pulmonary Hypertension Stories of 2018    Pulmonary Hypertension News The top 10 pulmonary hypertension (PH) stories of 2018 dealt primarily with new strategies to diagnose and treat the disease.

NHS England funds Uptravi, for rare and incurable disease    The Pharma Letter Actelion Pharmaceuticals UK & Ireland, a subsidiary of US healthcare giant Johnson & Johnson (NYSE: JNJ) today announced that National Health *Service* ...